CORT
Corcept Therapeutics Incorporated · Healthcare
Chief Development Officer William Guyer sold $353K of Corcept Therapeutics Incorporated
Sold$353,000
$35.30Price
10,000Shares
−63%Stake
What CORT did after the filing
- The stock from Fri, Sep 6 open, $34.33
- +44.9%
- S&P 500, same days
- +6.6%
Measured over 30 trading days, to the Oct 18 close.
Traded Tue, Sep 3. Filed Thu, Sep 5, 8:04 PM ET, after the close. Returns use the Sep 6 open and the Oct 18 close. Not investment advice.